New President & CEO at Arbutus Bio | ABUS Message Board Posts

Arbutus Biopharma

  ABUS website

  • TECH UPDATE: Since we don't serve ads to Premium Members, our "premium" URL is not affected by the new code now required by our ad partners. So, rather than wait for us to resolve all these lovely new code conflicts suddenly plaguing our free, ad-supported "www" pages  (a process which will likely take days), Premium Members can enjoy full site functionality now by simply logging in to their premium accounts at https://premium.investorvillage.com If you need password assistance, don't hesitate to contact us. That's what we're here for.  


ABUS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34638 of 34692  at  6/17/2019 9:27:15 AM  by

Southerncross1


 In response to msg 34637 by  Steve_382
view thread

Re: New President & CEO at Arbutus Bio

 Viiv healthcare (where Mr. Collier served as president):  76.5% of the company is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi.  Has a significant market share of the HIV market. 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 193
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
34639 Re: New President & CEO at Arbutus Bio The Rooster 0 6/17/2019 10:30:22 AM


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...